CRI helped commission a poll of oncologists who say that much more research is required to holistically tackle non-small cell lung cancer.
The Cancer Research Institute and Lance Kawaguchi with the #SouthPoleTrek4Cancer ring in the Nasdaq Stock Market Closing Bell.
CRI's 2023 Patient Immunotherapy Summit is now available on-demand for the benefit of cancer patients, families, caregivers, and scientists.
The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.
Michael Berger, PhD, has been awarded a grant by The Israel Cancer Research Fund (ICRF) and the Cancer Research Institute (CRI).
The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research
The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.
Fern Lazar, Managing Partner and Global Health Practice Leader at FINN Partners, was elected to the Cancer Research Institute’s Board of Trustees.
The Cancer Research Institute is honoring Dr. Tak Mak with the prestigious 2023 William B. Coley Award.
Global celebration of 11 years of discovery and lifesaving innovation in immuno-oncology
The immuno-oncology (IO) clinical trial landscape is shifting in new directions. While the number of total clinical trials is down, there are healthy signs of innovation.
Lance Kawaguchi, an internationally recognized executive leader and board member with over 25 years of global finance and banking experience, will be undertaking a monumental Trek to the South Pole in December 2023 to raise funds for several charities, including the Cancer Research Institute (CRI). Serving as a strategic advisor, he has pledged to lead a global effort to raise awareness and funds for CRI.
Free online event for cancer patients and caregivers featuring immunotherapy experts and patient advocates taking place Nov. 11-12, 2022.
The CRI-ICRF Clinic and Laboratory Integration Program (CLIP) Grant to Fund Promising Immunotherapy Research in Israel Is Awarded to Yifat Merbl, PhD, of the Weizmann Institute of Science.
The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the immune system’s power to control and potentially cure all types of cancer, will confer its prestigious 2022 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology on four scientists for their collective work that revealed the role of the pore-forming gasdermins in pyroptosis and promotion of anti-tumor immunity, setting the stage for targeting gasdermins in cancer therapeutics.
El Cancer Research Institute (CRI), una organización sin fines de lucro consagrada a aprovechar la capacidad del sistema inmunitario para combatir y potencialmente curar todos los tipos de cáncer, ofrecerá su segunda Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer, el 22 de septiembre de 2022, de 2 a 5 p. m. (hora del este).
The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET.
Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with the potential to transform cancer treatment
Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends and real-world usage, highlights key challenges including effective solid tumor targeting, manufacturing complexities, and commercial access to approved therapies
Global celebration of 10 years of discovery and lifesaving innovation in immuno-oncology
A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment.
A new report from the Cancer Research Institute on the global landscape of PD1/PDL1 immunotherapy clinical development
CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.
CRI's Online Immunotherapy Patient Summit connects cancer patients and caregivers to scientific and medical experts, explores clinical trials, cancer care disparities
El Cancer Research Institute (CRI), organización sin fines de lucro liderando investigación revolucionaria sobre el poder de nuestro sistema inmunológico para controlar y potencialmente curar todos los tipos de cáncer, ofrecerá su primera Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer 2021 totalmente en español, el 16 de septiembre de 2021, de 2 a 5 p.m. (hora del este).
The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its first-ever Virtual Cancer Immunotherapy Summit in Spanish on September 16, 2021, 2-5 p.m. ET.
Cancer Research Institute announced grants and fellowships of $28.5 million to scientists advancing immunology and cancer immunotherapy research
Cancer Research Institute announces first recipients of new fellowship program designed to promote racial diversity and inclusion in immunology and tumor immunology
El Cancer Research Institute anunció hoy que ha lanzado su primer website en español para conectar a los pacientes hispanos y sus cuidadores con la información más reciente sobre la inmunoterapia contra el cáncer y las opciones de tratamiento.
The Cancer Research Institute (CRI) announced today that is has launched its first-ever Spanish-language information hub to connect Hispanic patients and caregivers with the latest cancer immunotherapy research and treatment options.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right